Request Demo
Last update 21 Feb 2025
HB0056
Last update 21 Feb 2025
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms Targeting TSLP and IL-11 IgG1-type Bispecific Antibody(Shanghai Huaaotai Biopharmaceutical) |
Target |
Mechanism IL-11 modulators(interleukin 11 modulators), TSLP modulators(Thymic stromal lymphopoietin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with HB0056NCT06612970
A Phase 1a, Randomized, Double-blind, Placebo-controlled, Single Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HB0056 in Adult Healthy Subjects.
100 Clinical Results associated with HB0056
Login to view more data
100 Translational Medicine associated with HB0056
Login to view more data
100 Patents (Medical) associated with HB0056
Login to view more data
100 Deals associated with HB0056
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 1 | NZ | 18 Nov 2024 | |
| Dermatitis, Atopic | Phase 1 | NZ | 18 Nov 2024 | |
| Idiopathic Pulmonary Fibrosis | Phase 1 | NZ | 18 Nov 2024 | |
| Pulmonary Disease, Chronic Obstructive | Phase 1 | NZ | 18 Nov 2024 | |
| Moderate asthma | IND Approval | CN | 21 Feb 2025 | |
| Severe asthma | IND Approval | CN | 21 Feb 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free